Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03010022 dhk PGD2 cPLA2i 1.0 BCD110605C28 0.258 pmol/ml medium
LMFA03010022 dhk PGD2 cPLA2i 1.0 BCD110605C30 0.299 pmol/ml medium
LMFA03010022 dhk PGD2 cPLA2i 1.0 BCD110605C29 0.488 pmol/ml medium
LMFA03010022 dhk PGD2 cPLA2i 20.0 BCD110605C64 0.46 pmol/ml medium
LMFA03010022 dhk PGD2 cPLA2i 20.0 BCD110605C66 0.426 pmol/ml medium
LMFA03010022 dhk PGD2 cPLA2i 20.0 BCD110605C65 0.404 pmol/ml medium
LMFA03010022 dhk PGD2 PLDi 1.0 BCD110605C16 0.203 pmol/ml medium
LMFA03010022 dhk PGD2 PLDi 1.0 BCD110605C17 0.243 pmol/ml medium
LMFA03010022 dhk PGD2 PLDi 1.0 BCD110605C18 0.254 pmol/ml medium
LMFA03010022 dhk PGD2 PLDi 20.0 BCD110605C54 0.349 pmol/ml medium
LMFA03010022 dhk PGD2 PLDi 20.0 BCD110605C52 0.484 pmol/ml medium
LMFA03010022 dhk PGD2 PLDi 20.0 BCD110605C53 0.696 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+cPLA2i 1.0 BCD110605C32 0.342 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+cPLA2i 1.0 BCD110605C31 0.365 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+cPLA2i 1.0 BCD110605C33 0.259 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+cPLA2i 20.0 BCD110605C68 0.527 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+cPLA2i 20.0 BCD110605C69 0.481 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+cPLA2i 20.0 BCD110605C67 0.616 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+PLDi 1.0 BCD110605C19 0.138 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+PLDi 1.0 BCD110605C20 0.272 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+PLDi 1.0 BCD110605C21 0.254 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+PLDi 20.0 BCD110605C56 0.527 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+PLDi 20.0 BCD110605C57 0.509 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+PLDi 20.0 BCD110605C55 0.596 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+ATP+cPLA2i 1.0 BCD110605C37 0.5 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+ATP+cPLA2i 1.0 BCD110605C38 0.236 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+ATP+cPLA2i 1.0 BCD110605C39 0.427 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+ATP+cPLA2i 20.0 BCD110605C74 0.714 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+ATP+cPLA2i 20.0 BCD110605C75 0.539 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+ATP+cPLA2i 20.0 BCD110605C73 0.447 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+ATP+PLDi 1.0 BCD110605C25 0.444 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+ATP+PLDi 1.0 BCD110605C27 0.548 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+ATP+PLDi 1.0 BCD110605C26 0.521 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+ATP+PLDi 20.0 BCD110605C61 0.859 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+ATP+PLDi 20.0 BCD110605C62 0.817 pmol/ml medium
LMFA03010022 dhk PGD2 KDO+ATP+PLDi 20.0 BCD110605C63 0.401 pmol/ml medium
LMFA03010022 dhk PGD2 KDO + ATP 1.0 BCD110605C15 0.385 pmol/ml medium
LMFA03010022 dhk PGD2 KDO + ATP 1.0 BCD110605C14 0.325 pmol/ml medium
LMFA03010022 dhk PGD2 KDO + ATP 1.0 BCD110605C13 0.39 pmol/ml medium
LMFA03010022 dhk PGD2 KDO + ATP 20.0 BCD110605C49 0.821 pmol/ml medium
LMFA03010022 dhk PGD2 KDO + ATP 20.0 BCD110605C50 0.786 pmol/ml medium
LMFA03010022 dhk PGD2 KDO + ATP 20.0 BCD110605C51 0.704 pmol/ml medium
LMFA03010022 dhk PGD2 KDO 1.0 BCD110605C08 0.159 pmol/ml medium
LMFA03010022 dhk PGD2 KDO 1.0 BCD110605C07 0.091 pmol/ml medium
LMFA03010022 dhk PGD2 KDO 1.0 BCD110605C09 0.323 pmol/ml medium
LMFA03010022 dhk PGD2 KDO 20.0 BCD110605C45 0.263 pmol/ml medium
LMFA03010022 dhk PGD2 KDO 20.0 BCD110605C44 0.334 pmol/ml medium
LMFA03010022 dhk PGD2 KDO 20.0 BCD110605C43 0.297 pmol/ml medium
LMFA03010022 dhk PGD2 C 0.0 BCD110605C03 0.06 pmol/ml medium
LMFA03010022 dhk PGD2 C 0.0 BCD110605C01 0.151 pmol/ml medium